ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

Funding opportunities listed.

June 4, 2004

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

August 31, 1984

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

PRI Fires Gilden, Compten, Sues For $1 Million By May Be Out Of Recompetition; NCI Is “Neutral”

August 8, 1986

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010